Warning letter
National Biochemicals Corp.: warning letter of Jul 14, 2000
FDA warning letter UCM068614 · Cincinnati District Office
Key facts
| Reference number | UCM068614 |
|---|---|
| Company | National Biochemicals Corp. |
| Subject | Bulk Drug Repacking & Distribution Facility/Active Pharmaceutical Ingredients/Animal Drug |
| Issue date | Jul 14, 2000 |
| Posted date | Jul 14, 2000 |
| Issuing office | Cincinnati District Office |
| Product type | Drugs |
| CFR sections cited | 20, 201.122, 201.150, 530, 530.1, 530.11(b), 530.13(a) |
| Country | 3 |
| Inspection city | Twinsburg |
| Inspection ZIP | 44087-2255 |
| Inspection start date | Feb 22, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: